
Sickle Cell Disease: Navigating Complexity in Clinical Practice
Activity Description
This course explores navigating sickle cell disease in clinical practice, including its epidemiology, pathophysiology, diagnosis, and common complications. Clinicians will evaluate current and emerging therapies and evidence-based strategies to improve management and prevention of SCD-related complications.
Target Audience
Learning Objectives
- Describe the epidemiology and pathophysiology of sickle cell disease (SCD)
- Identify diagnostic criteria and common complications of sickle cell disease
- Evaluate current and emerging therapies for sickle cell disease
- Apply evidence-based strategies to manage and prevent sickle cell disease complications
| Name | Role | Disclosure of Relevant Financial Relationships with Ineligible Company |
|---|---|---|
Kari Muskopf Occupational Therapist | Other licensed training | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Marlee Grounds Pharmacist | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Michelle Neumann Nurse | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Mohamed Radhi Physician | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Diva Presti Pharmacy Technician | Planner | No relevant financial relationship(s) with ineligible companies to disclose |
Alison Sutton Pharmacist | Independent Reviewer | No relevant financial relationship(s) with ineligible companies to disclose |
Disclosures of relevant financial relationships
In accordance with the Accreditation Council for Continuing Medical Education's (ACCME) Standards for Integrity and Independence in Accredited Continuing Education, Centene Institute for Advanced Health Education (Centene Institute) requires all those in control of educational content to disclose their financial relationships with ineligible companies within the prior 24 months. Ineligible companies are defined by the ACCME as companies whose primary business is producing, marketing, selling, re-selling or distributing health care products used by or on patients. Individuals must disclose all financial relationships, regardless of the amount, with ineligible companies and regardless of their view of the relevance of the relationship to the education. Centene Institute ensures that the content is independent of commercial bias.
None of the Centene Institute staff members have relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.


Universal Activity Number UAN JA4008309-0000-25-012-H01-P/T
Available Credit
- 0.50 ACPE Pharmacy
- 0.50 ACPE Technician
- 0.50 AMA PRA Category 1 Credit™
- 0.50 ANCC
- 0.50 Attendance/Participation
Since CE boards may have changes in requirements, it is the responsibility of the attendee to verify with their boards if they accept the CEs being offered.
Required Hardware/software
Please ensure you are using the web-browser Chrome and disable any pop-up blocking software.

Facebook
X
LinkedIn
Forward